Nucleocapsid as a next-generation COVID-19 vaccine candidate

Nucleocapsid as a next-generation COVID-19 vaccine candidate

Multiple new variants of the SARS-CoV-2 virus have emerged globally, due to viral mutation. The majority of COVID-19 vaccines contain SARS-CoV-2 spike protein, which is susceptible to mutation. It is known that protection against COVID-19 after two doses of mRNA vaccine continuously wanes over time....

Full description

Bibliographic Details
Main Authors: Bryan Oronsky, Christopher Larson, Scott Caroen, Farah Hedjran, Ana Sanchez, Elena Prokopenko, Tony Reid
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
SARS-CoV-2
Vaccine
Nucleocapsid
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222003794

Similar Items

Similar Items